Amedisys (AMED) Short Interest Ratio & Short Volume → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free AMED Stock Alerts $94.43 -0.52 (-0.55%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Amedisys Short Interest DataCurrent Short Volume2,310,000 sharesPrevious Short Volume2,390,000 sharesChange Vs. Previous Month-3.35%Dollar Volume Sold Short$212.64 millionShort Interest Ratio / Days to Cover8.3Last Record DateApril 30, 2024Outstanding Shares32,680,000 sharesFloat Size31,850,000 sharesShort Percent of Float7.25%Today's Trading Volume196,779 sharesAverage Trading Volume237,447 sharesToday's Volume Vs. Average83% Short Selling Amedisys ? Sign up to receive the latest short interest report for Amedisys and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAMED Short Interest Over TimeAMED Days to Cover Over TimeAMED Percentage of Float Shorted Over Time Ad True Market Insidersget a piece of the profit from this land This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024. Amedisys Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20242,310,000 shares $212.64 million -3.4%7.3%8.3 $92.05 4/15/20242,390,000 shares $218.33 million -4.0%7.5%8.7 $91.35 3/31/20242,490,000 shares $229.48 million -20.2%7.8%8.5 $92.16 3/15/20243,120,000 shares $290.82 million -0.3%9.8%10.8 $93.21 2/29/20243,130,000 shares $291.15 million +4.3%9.8%9.7 $93.02 2/15/20243,000,000 shares $281.31 million +1.4%9.4%9.9 $93.77 Get the Latest News and Ratings for AMED and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amedisys and its competitors with MarketBeat's FREE daily newsletter. 1/31/20242,960,000 shares $279.04 million +5.7%9.3%9.9 $94.27 1/15/20242,800,000 shares $263.98 million -2.8%8.8%9 $94.28 12/31/20232,880,000 shares $273.77 million +4.7%9.0%9.2 $95.06 12/15/20232,750,000 shares $260.01 million +9.1%8.6%7.9 $94.55 11/30/20232,520,000 shares $235.82 million +2.0%7.9%7.7 $93.58 11/15/20232,470,000 shares $231.19 million -5.7%7.8%6.7 $93.60 10/31/20232,620,000 shares $239.70 million +5.2%8.7%6.8 $91.49 10/15/20232,490,000 shares $231.35 million +6.4%8.3%6.2 $92.91 9/30/20232,340,000 shares $218.56 million +12.5%7.8%5.5 $93.40 9/15/20232,080,000 shares $194.96 million +26.1%6.9%4.7 $93.73 8/31/20231,650,000 shares $154.69 million +20.4%5.2%3.5 $93.75 8/15/20231,370,000 shares $127.18 million +8.7%4.3%2.6 $92.83 7/31/20231,260,000 shares $114.46 million -0.8%4.0%2.1 $90.84 7/15/20231,270,000 shares $115.54 million +8.6%4.0%1.8 $90.98 6/30/20231,170,000 shares $106.98 million -6.4%3.7%1.7 $91.44 6/15/20231,250,000 shares $114 million -49.4%3.9%1.9 $91.20 5/31/20232,470,000 shares $187.55 million -5.4%7.8%3.8 $75.93 5/15/20232,610,000 shares $194.42 million +22.0%8.2%4.7 $74.49 4/30/20232,140,000 shares $171.84 million +6.5%6.7%4 $80.30 4/15/20232,010,000 shares $162.93 million +5.8%6.3%4.8 $81.06 3/31/20231,900,000 shares $139.75 million +5.6%6.0%4.4 $73.55 3/15/20231,800,000 shares $139.41 million -13.9%5.7%4.1 $77.45 2/28/20232,090,000 shares $192.18 million +7.2%6.6%4.9 $91.95 2/15/20231,950,000 shares $188.90 million +7.1%6.1%4.7 $96.87 1/31/20231,820,000 shares $175.92 million +11.0%5.7%4.5 $96.66 1/15/20231,640,000 shares $139.24 million No Change5.2%3.5 $84.90 12/30/20221,640,000 shares $137.01 million +5.8%5.2%3.7 $83.54 12/15/20221,550,000 shares $130.25 million -1.9%4.9%3.4 $84.03 11/30/20221,580,000 shares $143.92 million -5.4%5.0%3.6 $91.09 11/15/20221,670,000 shares $150.80 million -2.3%5.3%3.8 $90.30 10/31/20221,710,000 shares $166.88 million -16.2%5.4%4 $97.59 10/15/20222,040,000 shares $186.97 million +3.6%6.4%5.4 $91.65 9/30/20221,970,000 shares $190.68 million No Change6.2%5.3 $96.79 9/15/20221,970,000 shares $236.40 million +15.2%6.2%5.1 $120.00CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (Ad)Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.Click on Adam's shiny forehead for more details. AMED Short Interest - Frequently Asked Questions What is Amedisys' current short interest? Short interest is the volume of Amedisys shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 2,310,000 shares of AMED short. 7.25% of Amedisys' shares are currently sold short. Learn More on Amedisys' current short interest. What is a good short interest ratio for Amedisys? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AMED shares currently have a short interest ratio of 8.0. Learn More on Amedisys's short interest ratio. Which institutional investors are shorting Amedisys? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Amedisys: Walleye Trading LLC, Concourse Financial Group Securities Inc., and Equitec Proprietary Markets LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Amedisys? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.25% of Amedisys' floating shares are currently sold short. Is Amedisys' short interest increasing or decreasing? Amedisys saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 2,310,000 shares, a decline of 3.3% from the previous total of 2,390,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Amedisys' float size? Amedisys currently has issued a total of 32,680,000 shares. Some of Amedisys' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Amedisys currently has a public float of 31,850,000 shares. How does Amedisys' short interest compare to its competitors? 7.25% of Amedisys' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Amedisys: Chemed Co. (2.01%), Addus HomeCare Co. (2.65%), AdaptHealth Corp. (11.25%), Option Care Health, Inc. (2.85%), iRhythm Technologies, Inc. (9.58%), IDEAYA Biosciences, Inc. (16.17%), 10x Genomics, Inc. (8.61%), SpringWorks Therapeutics, Inc. (13.51%), Xenon Pharmaceuticals Inc. (3.70%), Sotera Health (8.30%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Amedisys stock? Short selling AMED is an investing strategy that aims to generate trading profit from Amedisys as its price is falling. AMED shares are trading down $0.52 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Amedisys? A short squeeze for Amedisys occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AMED, which in turn drives the price of the stock up even further. How often is Amedisys' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AMED, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Chemed Short Interest Data Addus HomeCare Short Interest Data AdaptHealth Short Interest Data Option Care Health Short Interest Data iRhythm Technologies Short Interest Data IDEAYA Biosciences Short Interest Data 10x Genomics Short Interest Data SpringWorks Therapeutics Short Interest Data Xenon Pharmaceuticals Short Interest Data Sotera Health Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AMED) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaWhat’s Really Next for America…Porter & Company[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders